Asia-Pacific Neural Implants Market

Asia-Pacific Neural Implants Market Size, Share & Trends Analysis Report by Product (Deep Brain Stimulation (DCS), Spinal Cord Stimulation (SCS), and Vagus Nerve Stimulation (VNS)), by Application (Chronic Pain, Epilepsy, Parkinson's Disease (PD), and Others (Depression and Other Movement Disorders)), and by End-user (Hospitals, Outpatient Surgery Centers, and Specialized Neurological Centers (SNCs)) Forecast Period (2021-2027)
    Update Available - Forecast 2024-2030   

Published: May 2021 | Report Code: OMR2023488 | Category : Medical Devices | Delivery Format: /

The Asia-Pacific neural implants market is anticipated to grow at a healthy CAGR of 9.2% during the forecast period. Asia-Pacific accounted for the third-largest share in the global neural implants market. Some of the factors contributing to this region’s growth are the presence of a large pool of patient population, improvements in healthcare infrastructure, and increased healthcare expenditure. Further, the increasing prevalence of neurological diseases, including PD and other movement related disorders, and the aging population are the key factors boosting the growth of the neural implants market in the region. For instance, epidemiological studies reported, PD prevalence in the region is averaging 62 per 100,000 people. In addition, the Asia-Pacific region was estimated to have around 549 million people aged 60 years or over in 2019, which represents around 57% of the global elderly population. The percentage is projected to increase to 61% by 2050. Such a rapidly growing aging population are expected to have a higher risk of various neurological disorders, such as PD, and others, which will enhance the uptake of more neural implants.

The Asia-Pacific neural implants market is segmented based on product, application, and end-user. Based on the product, the neural implants market is segmented deep brain stimulation (DCS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). Based on application, the market is classified into Chronic Pain, Epilepsy, Parkinson's Disease (PD), and others (depression and other movement disorders). Based on end-user, the market is segmented into hospitals, outpatient surgery centers, and specialized neurological centers (SNCs). SCS product segment is estimated to be both, the largest and fastest growing segment for neural implants, during the forecast period.

Country-wise, the market is segmented into China, Japan, India, and the Rest of Asia-Pacific. Japan is expected to be the largest market for neural implants in Asia-Pacific, followed by China and Rest of Asia-Pacific. Japan has a robust and global standard regulatory body and reimbursement structure for medical devices. The growing geriatric population in the country is one of the primary reasons for the market growth of neural implants. For instance, the country has the highest number of people above 65 years of age. According to Japan’s Internal Affairs Ministry’s 2017 survey, the total elderly population hit a record of 35.14 million, accounting for 27.7% of the country’s total population.

Research Methodology

The market study of the Asia-Pacific neural implants market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  1. Asia-Pacific Neural Implants Market Research and Analysis by Product 
  2. Asia-Pacific Neural Implants Market Research and Analysis by Application
  3. Asia-Pacific Neural Implants Market Research and Analysis by End-user

The Report Covers

  • Comprehensive research methodology of the Asia-Pacific neural implants market.
  • This report also includes a detailed and extensive market overview with the key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific neural implants market.
  • Insights about market determinants which are stimulating the Asia-Pacific neural implants market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Key Strategy Analysis

3.2. Key Company Analysis

3.2.1. Overview

3.2.2. Financial Analysis

3.2.3. SWOT Analysis

3.2.4. Recent Developments

4. Market Determinants 

4.1 Motivators

4.2 Restraints

4.1. Opportunities 

5. Market Segmentation

5.1. Asia-Pacific Neural Implants Industry Market by Product

5.1.1. Deep Brain Stimulation (DCS)

5.1.2. Spinal Cord Stimulation (SCS)

5.1.3. Vagus Nerve Stimulation (VNS)

5.2. Asia-Pacific Neural Implants Market by Application

5.2.1. Chronic Pain

5.2.2. Epilepsy

5.2.3. Parkinson's Disease (PD)

5.2.4. Others (Depression and Other Movement Disorders)

5.3. Asia-Pacific Neural Implants Market by End-user

5.3.1. Hospitals

5.3.2. Outpatient Surgery Centers

5.3.3. Specialized Neurological Centers (SNCs)

6. Regional Analysis

6.1. China 

6.2. India 

6.3. Japan 

6.4. Rest of Asia-Pacific

7. Company Profiles

7.1. Abbott

7.2. Beijing PINS Medical Co., Ltd.

7.3. Boston Scientific Corporation

7.4. Medtronic

7.5. Renishaw plc

7.6. Saluda Medical Pty Ltd.

7.7. SceneRay Co., Ltd.

7.8. Synchron, Inc.*

*-Investigational Company

1. ASIA-PACIFIC NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)

2. ASIA-PACIFIC NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

3. ASIA-PACIFIC NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

4. ASIA-PACIFIC NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)

1. ASIA-PACIFIC NEURAL IMPLANTS MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)

2. ASIA-PACIFIC NEURAL IMPLANTS MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)

3. ASIA-PACIFIC NEURAL IMPLANTS MARKET SHARE BY END-USER, 2020 VS 2027 (%)

4. ASIA-PACIFIC NEURAL IMPLANTS MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)

5. CHINA NEURAL IMPLANTS MARKET SIZE, 2020-2027 ($ MILLION)

6. INDIA NEURAL IMPLANTS MARKET SIZE, 2020-2027 ($ MILLION)

7. JAPAN NEURAL IMPLANTS MARKET SIZE, 2020-2027 ($ MILLION)

8. REST OF ASIA-PACIFIC NEURAL IMPLANTS MARKET SIZE, 2020-2027 ($ MILLION)